导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 48.04% | 64/1050 |
| 近一周 | 3.61% | 40/1104 |
| 近一月 | -6.31% | 889/1103 |
| 近一季 | 1.47% | 228/1092 |
| 近半年 | 39.41% | 48/1070 |
| 近一年 | 62.57% | 53/1018 |
| 近两年 | 145.18% | 114/926 |
| 近三年 | 101.49% | 96/834 |
| 成立以来 | 82.37% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.29% 835/1070 |
107.09% 23/1101 |
- - |
- - |
| 2025 | 31.68% 447/1065 |
-2.62% 934/1014 |
-6.08% 980/1038 |
48.04% 96/1050 |
-2.75% 597/1065 |
| 2024 | 10.84% 267/1011 |
-3.63% 511/960 |
2.82% 161/983 |
8.96% 718/991 |
2.66% 214/1011 |
| 2023 | -3.42% 170/952 |
13.65% 61/880 |
4.23% 47/895 |
-12.48% 699/915 |
-6.84% 660/952 |
| 2022 | -26.70% 545/867 |
-21.48% 603/773 |
6.46% 439/806 |
4.81% 4/845 |
-16.35% 834/867 |
| 2021 | 37.11% 39/740 |
-13.54% 540/580 |
40.28% 10/659 |
4.57% 131/704 |
8.10% 124/740 |
| 2020 | 38.69% 305/554 |
-3.62% 253/419 |
40.49% 22/466 |
-0.58% 427/517 |
3.03% 468/554 |
| 2019 | 48.82% 159/410 |
26.09% 627/1149 |
-1.87% 509/1231 |
8.44% 140/390 |
10.92% 137/410 |
| 2018 | -31.41% 237/349 |
- - |
- - |
- - |
-12.13% 597/1080 |
| 2017 | 15.01% 105/285 |
- - |
- - |
- - |
- - |
| 2016 | -30.73% 147/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 招商移动互联网产业股票基金A VS. 东吴新产业精选股票A(580008) |